Your browser doesn't support javascript.
loading
Designing a vaccination strategy against dengue / Modelos para implementar a vacinação contra dengue
Amaku, Marcos; Coudeville, Laurent; Massad, Eduardo.
  • Amaku, Marcos; University of São Paulo. School of Veterinary Medicine. BR
  • Coudeville, Laurent; Sanofi Pasteur. Dengue Company. Lyon. FR
  • Massad, Eduardo; HCFMUSP. LIM. University of Sao Paulo. School of Medicine. BR
Rev. Inst. Med. Trop. Säo Paulo ; 54(supl.18): 18-21, Sept.-Oct. 2012. ilus, tab
Article in English | LILACS | ID: lil-649819
ABSTRACT
In this work we propose a mathematical approach to estimate the dengue force of infection, the average age of dengue first infection, the optimum age to vaccinate children against dengue in a routine fashion and the optimum age interval to introduce the dengue vaccine in a mass vaccination campaign. The model is based on previously published models for vaccination against other childhood infections, which resulted in actual vaccination programmes in Brazil. The model was applied for three areas of distinct levels of endemicity of the city of Recife in Northeastern State of Pernambuco, Brazil. Our results point to an optimal age to introduce the dengue vaccine in the routine immunization programme at two years of age and an age interval to introduce a mass vaccination between three and 14 years of age.
RESUMO
Neste trabalho propomos um modelo matemático para a estimativa da força de infecção, da idade média de primo-infecção, da idade ótima para vacinação de rotina e do intervalo ótimo de cobertura vacina em uma campanha para a introdução da vacina contra a dengue. O modelo baseia-se em publicações anteriores de desenhos de estratégias de vacinação contra outras infecções e que resultaram em estratégias de vacinação no Brasil. O modelo foi aplicado em três áreas com níveis endêmicos de dengue distintos na cidade de Recife, Pernambuco. Nossos resultados apontam para uma idade ótima de vacinação na rotina de dois anos de idade e para um intervalo de vacinação em campanha entre três e 14 anos.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Dengue / Dengue Virus / Dengue Vaccines Type of study: Prognostic study Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Infant / Infant, Newborn Country/Region as subject: South America / Brazil Language: English Journal: Rev. Inst. Med. Trop. Säo Paulo Journal subject: Tropical Medicine Year: 2012 Type: Article Affiliation country: Brazil / France Institution/Affiliation country: HCFMUSP/BR / Sanofi Pasteur/FR / University of São Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Dengue / Dengue Virus / Dengue Vaccines Type of study: Prognostic study Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Humans / Infant / Infant, Newborn Country/Region as subject: South America / Brazil Language: English Journal: Rev. Inst. Med. Trop. Säo Paulo Journal subject: Tropical Medicine Year: 2012 Type: Article Affiliation country: Brazil / France Institution/Affiliation country: HCFMUSP/BR / Sanofi Pasteur/FR / University of São Paulo/BR